Terms: = Bone cancer AND EPAS1, MOP2, 2034, ENSG00000116016, PASD2, HIF2A, Q99814 AND Treatment
6 results:
1. Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer.
Roberts KE; Adsett IT; Rickett K; Conroy SM; Chatfield MD; Woodward NE
Cochrane Database Syst Rev; 2022 Jan; 1(1):CD013167. PubMed ID: 35005781
[TBL] [Abstract] [Full Text] [Related]
2. Surgical treatment of Intraorbital Lesions.
Aftahy AK; Krauss P; Barz M; Wagner A; Meyer B; Negwer C; Gempt J
World Neurosurg; 2021 Nov; 155():e805-e813. PubMed ID: 34509678
[TBL] [Abstract] [Full Text] [Related]
3. A system-level approach identifies HIF-2α as a critical regulator of chondrosarcoma progression.
Kim H; Cho Y; Kim HS; Kang D; Cheon D; Kim YJ; Chang MJ; Lee KM; Chang CB; Kang SB; Kang HG; Kim JH
Nat Commun; 2020 Oct; 11(1):5023. PubMed ID: 33024108
[TBL] [Abstract] [Full Text] [Related]
4. Diseases of renal function and bone metabolism after treatment for early onset cancer: A registry-based study.
Liuhto N; Grönroos MH; Malila N; Madanat-Harjuoja L; Matomäki J; Lähteenmäki P
Int J Cancer; 2020 Mar; 146(5):1324-1332. PubMed ID: 31523804
[TBL] [Abstract] [Full Text] [Related]
5. Lower blood calcium associates with unfavorable prognosis and predicts for bone metastasis in NSCLC.
Shen H; Li Y; Liao Y; Zhang T; Liu Q; Du J
PLoS One; 2012; 7(3):e34264. PubMed ID: 22479582
[TBL] [Abstract] [Full Text] [Related]
6. Is there a dose-effect relationship for the treatment of symptomatic vertebral hemangioma?
Rades D; Bajrovic A; Alberti W; Rudat V
Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):178-81. PubMed ID: 12504051
[TBL] [Abstract] [Full Text] [Related]
